臺灣次世代基因定序檢測實作指引
1.0.0 - STU1.0.0

This page is part of the 臺灣次世代基因定序檢測實作指引 (v1.0.0: STU1.0.0) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

Example Condition: Lung adenocarcinoma

臨床狀態：Active ( ConditionClinicalStatusCodes#active)

驗證狀態：Confirmed ( ConditionVerificationStatus#confirmed)

病情、問題或診斷分類：Encounter Diagnosis ( Condition Category Codes#encounter-diagnosis)

病情、問題或診斷識別：右側支氣管或肺惡性腫瘤 ( 臺灣2023年中文版ICD-10-CM#C34.91)

病人：Patient/pat-min

診斷日期：2024-07-10

申請理由：完整 Foundation Medicine 檢測報告請看報告查詢系統中”分子病理室檢查報告之附件”，其內容包含腫瘤的基因突變、腫瘤突變負荷(TMB)、微衛星體不穩定性(MSI)相關資訊，並針對病患接受癌症標靶治療或免疫治療提供建議